Cerulean Scientific · Durham, NC
A different
surface.
A new possibility.
Developing a physical approach to biofouling resistance in medical devices.
Explore the platform
Development-stage technology. Not cleared through FDA 510(k) and not available for sale in the United States.
The science of staying clear
Start with the surface.
Device obstruction begins at an interface. Cerulean is developing surface technologies designed to reduce adhesion, rather than relying on an antibiotic coating.
See the physical approach
the interface.
Two fields. One platform.
Follow the
application.
Explore the neurosurgical and vascular development programmes, then connect with the team about research or product partnerships.
Clearer pathways.
Ventricular catheters and external ventricular drains.
02 / Vascular
A different interface.
Haemodialysis catheters and vascular graft development.
03 / PartnershipsBring a question.
Build a conversation.
Talk to Cerulean about the technology, scientific collaboration or commercial development.